Forward Management Cut Its Ubs Group Ag (UBS) Position as Stock Value Rose; Abbvie Com Usd0.01 (ABBV) Stock Value Rose While Beck Capital Management Has Lifted Position by $2.27 Million

February 16, 2018 - By Peter Erickson

Beck Capital Management Llc increased its stake in Abbvie Inc Com Usd0.01 (ABBV) by 271.77% based on its latest 2017Q3 regulatory filing with the SEC. Beck Capital Management Llc bought 25,824 shares as the company’s stock rose 6.17% with the market. The institutional investor held 35,326 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $3.14M, up from 9,502 at the end of the previous reported quarter. Beck Capital Management Llc who had been investing in Abbvie Inc Com Usd0.01 for a number of months, seems to be bullish on the $188.45B market cap company. The stock increased 2.74% or $3.143 during the last trading session, reaching $118.043. About 4.48 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 16, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Forward Management Llc decreased its stake in Ubs Group Ag (UBS) by 24.93% based on its latest 2017Q3 regulatory filing with the SEC. Forward Management Llc sold 32,309 shares as the company’s stock rose 6.96% with the market. The institutional investor held 97,266 shares of the major banks company at the end of 2017Q3, valued at $1.67 million, down from 129,575 at the end of the previous reported quarter. Forward Management Llc who had been investing in Ubs Group Ag for a number of months, seems to be less bullish one the $67.82 billion market cap company. The stock increased 0.57% or $0.11 during the last trading session, reaching $19.3. About 1.08 million shares traded. UBS Group AG (NYSE:UBS) has risen 14.86% since February 16, 2017 and is uptrending. It has underperformed by 1.84% the S&P500.




Among 12 analysts covering UBS AG (NYSE:UBS), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. UBS AG had 21 analyst reports since September 15, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, November 10 by Keefe Bruyette & Woods. Bank of America upgraded the stock to “Buy” rating in Friday, November 10 report. Morgan Stanley upgraded the stock to “Overweight” rating in Tuesday, December 6 report. The rating was upgraded by JP Morgan on Monday, December 12 to “Neutral”. The rating was downgraded by JP Morgan to “Underweight” on Monday, June 27. The stock of UBS Group AG (NYSE:UBS) has “Neutral” rating given on Wednesday, February 24 by Macquarie Research. The firm has “Sector Perform” rating given on Wednesday, October 5 by RBC Capital Markets. Bank of America upgraded the shares of UBS in report on Tuesday, February 7 to “Neutral” rating. Kepler Cheuvreux downgraded UBS Group AG (NYSE:UBS) on Tuesday, February 9 to “Hold” rating. The stock of UBS Group AG (NYSE:UBS) has “Buy” rating given on Wednesday, October 7 by Bank of America.

Forward Management Llc, which manages about $5.17 billion and $893.11 million US Long portfolio, upped its stake in Unilever Plc (NYSE:UL) by 14,148 shares to 58,354 shares, valued at $3.38M in 2017Q3, according to the filing. It also increased its holding in Ambev Sa (NYSE:ABEV) by 70,754 shares in the quarter, for a total of 422,168 shares, and has risen its stake in Government Pptys Income Tr (NYSE:GOV).

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, March 10 by Goldman Sachs. The firm has “Outperform” rating given on Monday, October 30 by Leerink Swann. SunTrust maintained it with “Buy” rating and $105.0 target in Sunday, October 29 report. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Thursday, January 4. The rating was downgraded by Citigroup on Monday, November 28 to “Neutral”. The company was maintained on Friday, October 13 by UBS. The firm earned “Buy” rating on Friday, August 18 by Jefferies. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Sunday, July 30 by BMO Capital Markets. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Friday, April 28 by BMO Capital Markets. On Monday, June 26 the stock rating was maintained by Jefferies with “Buy”.

Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.15, from 1 in 2017Q2. It turned negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Naples Glob Advisors Limited Liability Corp holds 30,979 shares or 0.92% of its portfolio. King Luther Capital has invested 1.92% in AbbVie Inc. (NYSE:ABBV). Sonata Grp holds 3,820 shares or 0.25% of its portfolio. Moreover, Symphony Asset Lc has 0.18% invested in AbbVie Inc. (NYSE:ABBV) for 18,149 shares. Cadence Commercial Bank Na holds 0.57% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 16,891 shares. Hbk Sorce Advisory Ltd Llc, Pennsylvania-based fund reported 13,227 shares. Shamrock Asset Mgmt Ltd Company reported 0.16% of its portfolio in AbbVie Inc. (NYSE:ABBV). 120,093 were accumulated by Wendell David Incorporated. Rhumbline Advisers holds 0.47% or 2.44M shares. Retail Bank has 0.23% invested in AbbVie Inc. (NYSE:ABBV). Daiwa Sb has invested 0.02% in AbbVie Inc. (NYSE:ABBV). Cubic Asset Management Limited Liability Corp stated it has 45,260 shares or 1.13% of all its holdings. West Family holds 0.24% or 22,000 shares. Focused Wealth Mgmt holds 2,217 shares or 0.07% of its portfolio. Moreover, Panagora Asset has 0.26% invested in AbbVie Inc. (NYSE:ABBV) for 750,523 shares.

Beck Capital Management Llc, which manages about $200.00 million and $209.42M US Long portfolio, decreased its stake in Amazon.Com Inc (NASDAQ:AMZN) by 1,523 shares to 6,600 shares, valued at $6.35 million in 2017Q3, according to the filing. It also reduced its holding in Goldman Sachs Bdc Inc Shs (NYSE:GS) by 88,793 shares in the quarter, leaving it with 63,724 shares, and cut its stake in Facebook Inc Com Usd0.000006 Cl A (NASDAQ:FB).

Since September 11, 2017, it had 0 insider buys, and 5 insider sales for $25.59 million activity. Michael Robert A. sold $589,512 worth of stock. 87,040 shares were sold by RICHMOND TIMOTHY J., worth $8.57 million on Monday, December 18. Gosebruch Henry O sold $1.66M worth of stock. On Thursday, December 14 Schumacher Laura J sold $14.07 million worth of AbbVie Inc. (NYSE:ABBV) or 145,510 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.